Quoin Pharmaceuticals Ltd DRC (QNRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $17.78M
Last updated: Nov 17, 2026 at 4:10 PM ET
Quoin Pharmaceuticals Ltd DRC (QNRX) Stock Chart
Quoin Pharmaceuticals Ltd DRC (QNRX) has a latest price of $3.46 on Nov 17, 2026, 85.3% below its 52-week high of $23.50. Its price fell 77.0% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 68.3%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $975,914.84 in Oct 2017 and its lowest $4.45 in Jul 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart QNRX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for QNRX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 26.7%, and over 6 months it fell 33.1%. The month-end price fell 96.8% over the 3 years through Oct 2026, a compound annual decline of 68.3%.
| Period | Change |
|---|---|
| 1 month | -13.1% |
| 3 months | -26.7% |
| 6 months | -33.1% |
| 12 months | -77.0% |
| 12 months, with dividends | -77.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -96.8% | -68.3% |
| 5 years | -100.0% | -85.1% |
| 10 years | -100.0% | -68.3% |
Price by Year
Its best calendar year was 2017, when the price rose 126.5%, and its weakest was 2022, when it fell 93.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $4.54 | -68.5% |
| 2025 | $14.43 | -36.6% |
| 2024 | $22.75 | -86.7% |
| 2023 | $171.50 | -71.2% |
| 2022 | $596.04 | -93.8% |
| 2021 | $9,549.27 | -78.9% |
| 2020 | $45,332.82 | -2.7% |
| 2019 | $46,592.06 | -78.9% |
| 2018 | $220,367.87 | -70.0% |
| 2017 | $734,559.56 | +126.5% |
Trading Range
The price is 28.7% below its 50-day average of $4.85 and 39.5% below its 200-day average of $5.72.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.46 | |
| 52-week high | $23.50 | -85.3% |
| 52-week low | $3.25 | +6.5% |
| 50-day average | $4.85 | -28.7% |
| 200-day average | $5.72 | -39.5% |
Price Risk
Over 3 years, its largest fall from a peak was 98.3%.
| Measure | Value |
|---|---|
| 1-year beta | 0.83 |
| Largest fall, 1 year | -85.4% |
| Largest fall, 3 years | -98.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About QNRX
What is QNRX's 1-year price change?
Quoin Pharmaceuticals Ltd DRC's price fell 77.0% over the past 12 months. With dividends included, the 12-month total return was -77.0%.
What is QNRX's 5-year price change?
Quoin Pharmaceuticals Ltd DRC's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 85.1%. These figures leave out dividends.
What is QNRX's 52-week high and low?
Quoin Pharmaceuticals Ltd DRC's 52-week high is $23.50 and its 52-week low is $3.25. Its latest price of $3.46 on Nov 17, 2026 is 85.3% below the high.
What is QNRX's beta?
Quoin Pharmaceuticals Ltd DRC's 1-year beta against the S&P 500 is 0.83, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 85.4%.
Is the QNRX chart free?
Yes. Advanced Charting for QNRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
QNRX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors